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Abstract
Background This study was performed to investigate the in-
cidence and etiology of ventriculostomy-related infections
(VRIs) in patients with subarachnoid hemorrhage (SAH) and
to assess adherence to local clinical guidelines regarding em-
pirical antimicrobial therapy and diagnostic routines.
Methods A total of 191 consecutive SAH patients treated in
the neuro-intensive care unit of Uppsala University Hospital
between 2010 and 2013 were included retrospectively.
Information regarding cerebrospinal fluid samples, bacterial
cultures, ventriculostomy treatment, patient characteristics,
and antibiotic treatment were collected from electronic patient
records.
Results Eleven patients developed VRI, resulting in an inci-
dence of 5.8% per patient, 5.4% per ventriculostomy catheter,
and 4.1 per 1000 catheter days. Coagulase-negative staphylo-
cocci caused nine cases of VRI and Klebsiella pneumoniae
and Staphylococcus aureus caused one each. Empirical VRI
therapy was initiated on 97 occasions in 81 subjects (42.4%).
Out of the 11 patients with VRI, four did not receive empirical
antibiotic therapy before the positive culture result. The clin-
ical actions performed after analysis of CSF samples were in
line with the action suggested by the local guidelines in 307
out of 592 cases (51.9%).
Conclusions The incidence of VRI in our cohort was compa-
rable to what has previously been reported. Coagulase-
negative staphylococci was the most common agent. Our
study demonstrates the difficulty in diagnosing VRI in SAH
patients. Improved adherence to clinical guidelines could to
some extent reduce the use of empirical antibiotic treatment,
but better diagnostic methods and routines are needed.
Keywords Ventriculostomy .Meningitis . Subarachnoid
hemorrhage . Antimicrobial therapy
Introduction
Subarachnoid hemorrhage (SAH) is a severe condition, caus-
ing substantial morbidity and mortality [16, 35]. The manage-
ment of patients with SAH is centered on the prevention of
rebleeding by occluding the aneurysm and minimizing sec-
ondary brain insult by preventing and treating complications
such as vasospasm, hydrocephalus, increased intracranial
pressure (ICP), and infections. To monitor ICP and to treat
secondary hydrocephalus, ventriculostomy catheters are often
used. This management may increase the risk of infection, as
microorganisms can colonize the device and spread to cere-
brospinal fluid (CSF) and meninges to cause meningitis or
ventriculitis [6]. These infections are called ventriculostomy-
related infections (VRIs). Functional outcome and mortality
after SAH is multifactorial and the exact impact of VRIs is not
yet known. Severa l fac tors such as dura t ion of
ventriculostomy treatment [1, 2, 23, 26, 33, 37], irrigation of
the ventriculostomy catheter [2, 7, 26], and presence of intra-
ventricular blood [2, 23, 26, 37] have been shown to increase
the risk of a VRI. The incidence of VRIs has varied signifi-
cantly in previous studies, but a 2002 meta-analysis showed
an incidence of 8.8% per pat ient treated with a
ventriculostomy catheter [21]. Lumbar CSF drainage has been
suggested as an alternative to ventriculostomy, possibly with a
lower risk of intracerebral hemorrhage, vasospasm, and faster
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clearance of subarachnoid blood clots [18, 24, 36]. Lumbar
drainage carries the disadvantage of not allowing reliable ICP
monitoring, limiting its clinical usefulness. Whether increased
use of lumbar drainage could affect VRI rates is not known.
The diagnosis of VRIs in the SAH setting is challenging as
the underlying disease may cause fever, nuchal stiffness, head-
ache, and lowered consciousness [27]. Moreover, interpreta-
tion of routine laboratory analyses of CSF such as cell count,
glucose, albumin, and lactate is complicated by the presence
of intraventricular blood and inflammation, either from the
initial bleed or surgical interventions. This can affect the reli-
ability of these parameters to indicate CNS infection [32].
Standard CSF bacterial cultures have long remained the gold
standard for diagnosing VRIs but carry the disadvantage that
they take several days to complete, making empirical treat-
ment necessary in patients at risk. It has also been discussed
whether standard culturesmight have limitations in sensitivity,
with reports of culture-negative but PCR-positive samples in
patients with suspected VRI [3]. This has led to debate on how
VRIs should be diagnosed and monitored and when empirical
treatment should be considered. Several strategies have been
proposed such as routine CSF cultures in all patients with
ventriculostomy catheters, calculation of indices relating cell
count in CSF to blood [30], and the analysis of CSF lactate as
a reliable indicator of VRI [19, 25]. Hitherto, no consensus has
been reached.
The aim of this study was to investigate the incidence and
bacteriological etiology of VRI in patients with SAH that have
been treated with a ventriculostomy catheter in the neuro-
intensive care unit (neuro-ICU) of Uppsala University
Hospital during the period 2010–2013. Further objectives
were to investigate the extent of empirical antibiotic treatment
for VRI and adherence to local guidelines for VRI diagnostics
and treatment.
Materials and methods
In total, 228 consecutive patients with spontaneous SAH treat-
ed with a ventriculostomy catheter were retrospectively
screened for inclusion in the study. All patients were treated
at the Department of Neurosurgery at Uppsala University
Hospital between January 2010 and December 2013. The de-
partment has a catchment area of approximately 2 million
inhabitants and is supported daily by infectious disease spe-
cialists. Patients were admitted to the neuro-ICU when a di-
agnosis of SAH had been radiologically verified, excluding
patients considered terminally ill. In total, 37 patients fulfilled
one or more exclusion criteria (Table 1), leaving 191 subjects
for further analysis.
A ventriculostomy catheter was placed in all SAH patients
not responding to commands. The catheter was placed
through a frontal lobe burr hole and was fixated with sutures
after at least 5 cm subcutaneous tunneling. No catheters with
antimicrobial coating were used. Two grams of cloxacillin
was administered intravenously at the start of surgery and
further doses of 1 g were given every third hour during sur-
gery. Clindamycin, 600 mg at the start of surgery and 300 mg
every third hour, was used if subject was allergic to penicillin.
A closed ventriculostomy system was used and CSF samples
were collected upon clinical signs of infection such as onset of
fever, unexplained rise in system inflammatory parameters, or
deteriorating neurological performance. The catheters were
not routinely exchanged.
Information was extracted from electronic patient records
regarding age, gender, time of bleeding, aneurysm interven-
tion, time of ventriculostomy placement, length of
ventriculostomy treatment, volume of CSF drained, number
of samples and cultures collected from CSF, antibiotic treat-
ment, results of laboratory tests of CSF (cell counts, glucose,
lactate, and albumin) and peripheral blood (white cell count,
C-reactive protein (CRP), and plasma glucose) as well as the
results of all bacterial cultures. Data from 758 occasions of
CSF and blood sampling were collected. Antibiotic use direct-
ed against VRI was estimated by multiplying number of days
of VRI treatment with standard VRI dosage of the drugs used.
Antibiotic use was estimated in defined daily doses (DDD).
Cultures were performed at the Department of Clinical
Microbiology and Hospital hygiene and analysis of CSF was
performed at the Department of Clinical Chemistry and
Pharmacology, both at Uppsala University Hospital. Data re-
garding clinical parameters (Fisher grade [13], World
Federation of Neurological Surgeons SAH-grade (WFNS)
[28] and Glasgow coma scale motor response (GCS motor)
[38]) on admittance were collected from electronic health
records.
Clinical decisions regarding initiation of antibiotic treat-
ment and CSF sampling for culture were registered and com-
pared to the recommendations in local management guidelines
(Table 2). VRI cases were defined as positive CSF culture
along with inflammatory parameters above a pre-defined
threshold in CSF. The definition of inflammation in CSF
was the same as the criteria used in the local guidelines for
when to send CSF for cultures (Table 2).
Statistical analysis was performed using R version 3.0.1
(The R Foundation for Statistical Computing. Vienna,
Austria). Statistical comparisons were made using the non-
Table 1 List of patients excluded from the study
Reason for exclusion Number of patients
Wrong diagnosis 4
Substantial neuro-ICU-care in another hospital 17
Management affected by other clinical study 16
Total 37
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parametric Mann–Whitney U test and Fisher’s exact test. The




Data regarding subject age, gender, clinical status on admit-
tance according to GCS-motor and WFNS, radiological status
according to Fisher grade, as well as data on length of
ventriculostomy catheter treatment, volume of drained CSF,
number of CSF samples, and aneurysm intervention are
shown in Table 3. The VRI group had longer duration of
ventriculostomy catheter treatment, larger CSF draining vol-
umes, and more CSF samples drawn. There were no signifi-
cant differences between the VRI and non-VRI groups regard-
ing age, gender, aneurysm intervention, or clinical and radio-
logical status on admittance.
Incidence of VRI
In the 191 subjects included for analysis, a total of 205
ventriculostomy catheters were inserted. In 14 subjects,
more than one ventriculostomy catheter was placed. The
ventriculostomy catheters were kept for amedian of 13 days,
giving a total of 2683 catheter days. From the 758 CSF
samples taken, bacteriological culture was performed on
453. In total, 26 cultures from 18 different patients present-
ed with bacterial growth. There were seven patients (3.1%)
with positive bacterial cultures that were classified as colo-
nization of the catheter or contamination of the sample rath-
er than VRI, due to lack of inflammatory signs in CSF. Out
of 191 study subjects, 11 were considered to have developed
VRI, resulting in an incidence of 5.8% per patient, 5.4% per
ventriculostomy catheter, and an infection rate of 4.1 per
1000 catheter days.
Microbiology
In the 11 cases defined as VRI, nine were caused by
coagulase-negative staphylococci, one by Klebsiella
pneumoniae, and one by Staphylococcus aureus. In the group
of patients with positive CSF cultures that were regarded as
contaminations, four were coagulase-negative staphylococci
and there was one case of Micrococcus spp., alpha-
hemolytic streptococci and diphteroids, respectively.
Antimicrobial treatment
Empirical antibiotic treatment for bacterial meningitis was
given to 81 (42.4%) of the patients on 97 occasions at some
point during neuro-ICU care (Table 1). Eight of these patients
(9.9%) had positive cultures and five represented VRIs ac-
cording to the study definitions. Among the VRI cases con-
firmed by bacterial culture, four did not receive any empirical
antibiotic treatment before the culture results and two subjects
received therapy with only one drug (meropenem in one case
and vancomycin in one case). In one case of VRI, the patient
was admitted to another hospital shortly after the sample had
been collected and no records of further treatment could be
found. In 47 of 88 cases with a negative CSF culture, empir-
ical treatment was discontinued within 72 h.
The local first-line recommendation for empirical treatment
of VRI is cefotaxime in combination with vancomycin. The
second-line treatment is meropenem in combination with van-
comycin. Cefotaxime, vancomycin, and meropenem were the
most commonly used antibiotics in the study (Fig. 1). Due to
suspected allergic reaction, second-line treatment with
trimetoprim-sulfamethoxazole was given in one case.
Penicillin was used in one case to treat alpha-hemolytic strep-
tococci found in CSF culture. Moxifloxacin in combination
with intrathecal gentamycin was used in one case to treat
Klebsiella pneumoniae. In one case, due to poor CSF penetra-
tion of vancomycin, rifampicin was used.
In cases where sufficient data were available, the total
amount of VRI therapy was calculated in defined daily doses
(DDD). In 177 patients, the total antibiotic treatment directed
Table 2 Local guidelines for
indications of CSF culture and
empirical treatment
Send CSF for bacterial culture* Initiate treatment for VRI*
Corrected CSF polynuclear leucocytes** >50 × 106/l >250× 106/l***
CSF lactate >3.5 mmol/l >4.0 mmol/l
CSF plasma glucose ratio <0.4 <0.35
CSF albumin >0.40 g/l
*If one or several of criteria are fulfilled
**Calculated as CSF-polynuclear leucocytes - CSF-erythrocytes/1000
***Or a marked rise from previous sample (a definition of a marked rise is not given in the clinical guidelines. In
our study, a marked rise was defined as a doubling of corrected polynuclear leucocyte count between two samples
taken within 48 h, resulting in a value of >100× 106 /l)
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against VRI was estimated as 1471 DDD. To evaluate the
potential of a rapid diagnostic method for VRI for reducing
unnecessary use of antibiotics in the neuro-ICU, the total
amount of empirical VRI treatment, given in patients where
a negative CSF culture resulted in discontinuation of therapy,
was estimated. In these 34 cases, 398 DDD of empirical VRI
therapy (27.1% of total VRI therapy) was given.
Adherence to local guidelines
To investigate adherence to local guidelines (Table 2), results
from the CSF diagnostic work-up available at the time of
decision were compared to the actual clinical decisions re-
garding CSF cultures and empirical VRI treatment (Fig. 2).
For this analysis, all CSF samples collected during VRI treat-
ment were excluded, resulting in a total of 592 CSF samples
where the clinical action could be compared to the local
guidelines.
The clinical action performed after each of the 592 CSF
samples was in line with the action suggested by the clinical
guidelines in 307 cases (51.9%). The deviations from guide-
lines included initiation of empirical VRI treatment, sending
CSF for culture when the inflammatory signs were not suffi-
cient and also omitting to do so when sufficient inflammatory
signs were present. There were 307 samples that presented
with such limited inflammatory signs that no action was rec-
ommended. In 141 (45.9%) of these, the clinician sent CSF for
culture. This resulted in nine positive cultures, all regarded as
contaminations according to the study definitions. In another
11 of the 307 cases with little to no inflammatory activity, VRI
treatment was initiated. There were 163 cases where the rec-
ommendation stated that CSF should be sent for culture. In 53
(32.5%) of these cases, no action was performed. In 19
(11.7%) cases, VRI treatment was initiated. In the 122 cases
when the inflammatory activity motivated VRI treatment,
such treatment was initiated in 60 (49.1%) cases. There were
62 cases where no treatment was initiated even though suffi-
cient inflammatory signs were present and in 20 of these no
culture was performed.
Discussion
In this study, 5.8% of the participants presented with a VRI,
which is slightly lower than the 8.8% incidence found in a
previous meta-analysis by Lozier et al. [21]. However, the
incidence reported in the studies included in this meta-
analysis used varying definitions of VRI that could affect the
results. Most of the studies used the criteria established by
Mayhall et al. [26], where VRI was defined as positive culture
of CSF drawn from ventriculostomy catheter or by lumbar
puncture. When using this definition in our study, the estimat-
ed VRI incidence is increased to 9.4%.
A number of studies have used more elaborate definitions of
VRI requiring either a second positive culture with the same
organism or inflammatory signs in CSF in conjunction with the
positive culture for VRI diagnosis [2, 22, 23, 33]. However,
due to the wide range of factors and cut-offs used to define the
inflammatory response in CSF, no head-to-head comparison is
possible. Surprisingly, out of all the studies included in the
meta-analysis, the two with the highest reported incidence [2,
33] were in the group using stricter definitions and the com-
bined incidence in the four studies using stricter definitions was
12.5%, higher than the average incidence of all included
Table 3 Patient characteristics.
All data reported as medians No VRI VRI p value*
Age (years) 60 58 0.46
Gender (male:female) 56:124 3:8 0.77
GCS motor on admittance (1–6) 6 5 0.44
WFNS on admittance (1–5) 4 4 0.89
Fisher grade (1–4) 4 4 1.0
EVD (days) 12 17 0.00085
Drainage volume per day (ml) 71 153 0.0011
Number of CSF samples drawn 4 8 5.76e-05
Aneurysm intervention (clipping:coiling:none) 53:118:9 1:10:0 0.29
*Using Mann–Whitney U test. For gender and aneurysm intervention, Fisher’s exact test was used
Fig. 1 Antibiotic treatment. One subject may have received several types
of treatment
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studies. This indicates that the variations in VRI incidence can-
not solely be explained by differences in diagnostic criteria.
Differences in epidemiology and ventricular catheter routines
[9] may also have influenced the VRI incidences reported.
It is clear that a more robust and universal definition of VRI
could enhance the quality of future research. Lozier et al. sug-
gested definitions of contamination, colonization, possible
VRI, VRI, and ventriculitis in their review and we believe
our definitions are in line with those suggestions. However,
using standard bacterial CSF culture as the gold standard for
VRI definition could be problematic since the test does not
strictly show the presence of bacteria, but rather their ability to
multiply. This ability could be impaired if patients are treated
with antibiotics penetrating to CSF, due to suspected VRI or
other infections, which is common in all ICU settings. Until
recently, no better alternative diagnostic test has been avail-
able but this might be subject to change in a near future.
The majority of VRIs in our study were caused by
coagulase-negative staphylococci. Most studies present simi-
lar results [10, 27, 29, 31, 32, 37] but in some a broader range
of pathogens were found, including varying rates of infections
with Gram-negative rods, Gram-positive cocci, and fungi [1,
14, 23, 40]. Growth of coagulase-negative staphylococci in
cultures is challenging for the clinician since they are often
contaminants and are generally considered a low-virulence
pathogen causing a relatively mild inflammatory response [4].
The extensive empirical VRI treatment compared to the
relatively low incidence of VRI in our material illustrates the
diagnostic difficulties and also gives and estimates the room
for improvement in reducing antibiotic use. Furthermore, it is
clear that clinical management guidelines are not always
followed with respect to CSF cultures and initiation of empir-
ical VRI treatment as additional factors are often taken into
consideration. In the 353 cases when culture was performed
on a subject not currently receiving VRI treatment, 141
(39.9%) were performed without the presence of inflammato-
ry signs in the CSF. Using our definition of VRI, the cases
with a positive culture result but without inflammation are
classified as contaminations, but it is also possible that an un-
known proportion of these represent actual VRIs with a limited
or delayed inflammatory response. An explanation of the exten-
sive use of CSF cultures could be that the clinical VRI guide-
lines do not include fever or changes in neurological status.
However, these symptoms are highly unspecific and do not
reliably indicate VRI [27]. It has also been shown that routine
cultures from patients with ventriculostomy catheters do not
identify infection earlier compared to an approach where sam-
pling and cultures are performed on clinical indications [15,
32]. We believe a stricter adherence to guidelines regarding
when to send CSF for culture could reduce over-diagnosing
and unnecessary antibiotic treatment.
The large use of empiricalVRI treatment is problematic from
an ecological perspective since high antibiotic pressure can lead
to selection of bacteria with pre-existing or inducible antibiotic
resistance, affecting the risk and severity of future infections.
Antibiotic treatment also increases the risk of complications
such as Clostridium difficile-associated diarrhea (CDAD).
Interestingly, even with this liberal use of empirical treatment,
six of 11 cases did not receive full empirical VRI treatment
before the positive result of the culture was obtained. Five of
these cases were caused by coagulase-negative staphylococci
and one case was caused by Staphylococcus aureus. In two of
these cases, empirical treatment should have been initiated ac-
cording to guidelines, and in four cases criteria for treatment
were not met before the positive culture result. There were also
62 cases when no treatment was initiated even though criteria
were met. In two of these cases, this delayed the initiation of
VRI treatment. This implies that a stricter application of guide-
lines would result in an even higher incidence of empirical
treatment, but could possibly reduce time to treatment for a
limited number of patients with VRI. The guidelines state that
the treatment should be discontinued if CSF cultures are nega-
tive after 48–72 h [8]. These routines have not been assessed in
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Fig. 2 Results of CSF samples in relation to recommendations in clinical guidelines, actual clinical action, and result of cultures. Samples taken during
VRI treatment excluded
approach is safe [40]. In our dataset, empirical treatment was
sometimes continued for several days or even weeks although
culture results were negative. This could partly be explained by
the fact that a substantial part of all CSF samples were collected
during antimicrobial treatment that could negatively influence
the sensitivity of CSF cultures. However, a stricter approach in
discontinuing empirical VRI therapy could help to reduce the
total antibiotic load.
In our study, VRI was associated with longer duration of
ventriculostomy treatment, larger volumes of CSF drainage,
and a higher number of CSF samples drawn. The association
to duration of ventriculostomy therapy has been previously
demonstrated [1, 26, 33] and further shows the importance of
rapidly removing ventriculostomy catheters when they are no
longer needed. Longer ventriculostomy treatment is associated
with larger drainage volumes and more sampling occasions,
explaining these overlapping correlations to VRI. The associa-
tion with increased sampling could also be due to the fact that
additional samples are collected after a VRI diagnosis has been
made, to monitor the effect of treatment. VRI can also elevate
ICP and hence increase the need for CSF drainage.
The limitations in using routine CSF inflammatory param-
eters to diagnose and predict VRI, and the frequent deviations
from clinical guidelines, indicate the need for better diagnostic
methods. The 48–72 h required for a reliable negative result
from CSF cultures is too long not to initiate empiric treatment
if there is clinical suspicion of a VRI. Our estimations on
antibiotic use for treating suspected or confirmed VRIs show
that approximately one-third of the antibiotic use could be
eliminated if faster diagnostic methods were available. PCR
of conserved bacterial nucleic acid sequences such as 16S-
rRNA is a rapid method that has become more widespread
and available to the clinician. There have been reports of
culture-negative cases of meningitis where PCR has been pos-
itive, indicating that cases of meningitis considered aseptic
could have a bacterial etiology [3, 11, 20]. PCR, however,
does not eliminate the problem of contamination, and frequent
detection of environmental bacteria has been pointed out as a
limitation [34]. Also, 16S-rRNA/rDNA do not specify the
pathogen sensitivity or resistance to antibiotics, which limit
the potential of reducing the use of broad-spectrum antibiotics.
There are promising emerging technologies such as PCR ESI-
MS, combining PCR with mass spectrometry for rapid detec-
tion of a broad range of pathogens [39] and the potential for
this method has been previously assessed in a neurosurgical
setting [5, 12]. It has also been reported that the method is
reliable for identifying different species of staphylococci [17],
which is interesting given the strong dominance of coagulase-
negative staphylococci in VRI. To clarify the potential role of
new diagnostic methods in the differentiation of aseptic and
septicmeningitis in patients with ventriculostomy, prospective
clinical studies, where new methods are compared head-to-
head with the current gold standard, are needed.
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Comments
This retrospective analysis of a considerable number of patients treated
with a ventriculostomy in the setting of subarachnoid hemorrhage
discusses the difficulties in arriving at a timely diagnosis of CSF
infection. Prophylactic treatment was initiated in cases of a significant
change in CSF cells or chemistry, fever, and neurological deterioration.
Infection was confirmed by positive cultures after a delay of several days.
The small percentage of infections prevented the identification of specific
procedures or parameters that could avoid this complication. The interest
of this manuscript is to highlight the difficulties in optimizing the
diagnosis of ventriculostomy-related infection following subarachnoid
hemorrhage. Evidenced-based technical nuances of catheter placement




Acta Neurochir (2017) 159:317–323 323
